Indeed, in head and neck cancer, overexpression of HPSE2 leads to increased SOX2 levels, reduced tumor growth and vascular density, and higher HPSE2 levels were associated with better survival of patients [10, 48, 49, 50]. The gene discussed is HPSE2; the disease is head and neck cancer.